524731 Stock Overview
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical formulations primarily in india.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Jenburkt Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹748.90 |
| 52 Week High | ₹925.00 |
| 52 Week Low | ₹586.90 |
| Beta | 0.59 |
| 1 Month Change | 5.58% |
| 3 Month Change | -9.73% |
| 1 Year Change | 6.35% |
| 3 Year Change | 77.21% |
| 5 Year Change | 54.80% |
| Change since IPO | 10,447.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524731 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.7% | -2.8% | -1.5% |
| 1Y | 6.3% | 54.9% | 45.0% |
Return vs Industry: 524731 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 524731 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 524731 volatility | |
|---|---|
| 524731 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524731 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524731's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 724 | Ashish Bhuta | www.jenburkt.com |
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical formulations primarily in india. it offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, anti-fungals, anti-ulcerants/antacids, aphrodisiacs, anti-malarials, anthelmintics, and anti- diabetics, as well as consumer products. The company provides its products through stockists and super stockists to doctors, chemists, large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. It also exports its products to approximately 13 countries worldwide.
Jenburkt Pharmaceuticals Limited Fundamentals Summary
| 524731 fundamental statistics | |
|---|---|
| Market cap | ₹3.31b |
| Earnings (TTM) | ₹244.49m |
| Revenue (TTM) | ₹1.38b |
13.5x
P/E Ratio2.4x
P/S RatioIs 524731 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524731 income statement (TTM) | |
|---|---|
| Revenue | ₹1.38b |
| Cost of Revenue | ₹321.72m |
| Gross Profit | ₹1.06b |
| Other Expenses | ₹817.03m |
| Earnings | ₹244.49m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 55.40 |
| Gross Margin | 76.74% |
| Net Profit Margin | 17.68% |
| Debt/Equity Ratio | 0.2% |
How did 524731 perform over the long term?
See historical performance and comparison